dallas semaglutide gastrointestinal obstruction class action gastric intestinal law office kentucky firm Dallas-Fort Worth Wegovy Lawsuit Lawyer semaglutide gastric intestinal obstruction law – dallas semaglutide gastrointestinal obstruction law

Weight Loss Specific Brands: Mounjaro vs Wegovy/Ozempic Mounjaro was FDA-approved in May 2022 for adults with type 2 diabetes, while Zepbound received approval in November 2023 for chronic weight management

While questions about long-term safety remain, the potential to improve patient outcomes by focusing on composition, not just weight, is worth watching as the full trial data emerges

Gastrointestinal side effects are the most commonly reported adverse events associated with retatrutide in clinical trials, consistent with the broader class of incretin-based therapies

Semaglutide acts on areas of the brain that regulate appetite, helping people feel fuller for longer, reducing hunger and decreasing food cravings